Jaju Pharmaceuticals Private Limited Company Logo

Jaju Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2002.

2002 | New Delhi, Delhi, India | Active
Last Updated:

About Jaju Pharmaceuticals Private Limited

Jaju Pharmaceuticals Private Limited, a active private limited company, was established on 17 September 2002 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231DL2002PTC117013. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.79 M.

It upholds a compliant status. Its leadership includes Pramod Kumar Jaju (Director), Saurabhraj Jaju (Director), Saharsh Jaju (Additional Director). It holds ₹1.10 M open charges and ₹0.95 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 6/51, Unit 23, Gf Tribhuvan Complex, Ishwar Nagar, Mathura, Road, New Delhi, Delhi, 110065.

Company Details

  • CIN/LLPIN

    U24231DL2002PTC117013

  • Registration Number

    117013

  • Incorporation Date

    17 September 2002

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.79 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.79 M
  • Company Age 23 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.10 M
  • Satisfied Charges ₹ 0.95 M
  • Revenue Growth 7.86%
  • Profit Growth -2.39%
  • Ebitda -4.80%
  • Net Worth 16.62%
  • Total Assets 46.34%
Company report

Jaju Pharmaceuticals Private Limited

Company Report FY 2025-2026

Explore comprehensive insights into Jaju Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element

Who are the key members and board of directors at Jaju Pharmaceuticals Private Limited?

Current Directors

NameDesignationAppointment DateStatus
Pramod Kumar JajuDirector17 Sep 2002Current
Saurabhraj JajuDirector17 Sep 2002Current
Saharsh JajuAdditional Director01 Apr 2024Current
Pooja JajuAdditional Director05 Aug 2024Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jaju Pharmaceuticals.

Jaju Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.86% increase. The company also saw a slight decrease in profitability, with a 2.39% decrease in profit. The company's net worth Soared by an impressive increase of 16.62%.

Jaju Pharmaceuticals revenue growth over time
Jaju Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
7.86%
Revenue from Operations
7.82%
Total Assets
46.34%
Profit or Loss
-2.39%
Net Worth
16.62%
EBITDA
-4.80%

What is the Ownership and Shareholding Structure of Jaju Pharmaceuticals?

In 2022, Jaju Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,100,000.00

Satisfied Charges

₹950,372.00

Charges Breakdown by Lending Institutions

  • Punjab National Bank : 0.11 Cr

Latest Charge Details

DateLenderAmountStatus
29 Mar 2010Punjab National Bank₹0.60 MOpen
29 Mar 2010Punjab National Bank₹0.50 MOpen
17 Nov 2003Punjab National Bank₹0.95 MSatisfied

Explore comprehensive loan charge details -

How Many Employees Work at Jaju Pharmaceuticals?

Unlock and access historical data on people associated with Jaju Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Jaju Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jaju Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaju Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Jaju Pharmaceuticals

Recent Activity within the Organization

  • Annual General Meeting

    Jaju Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Pooja Jaju was appointed as a Additional Director was appointed as a Additional Director on 05 Aug 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Director Appointment

    Progress on Saharsh Jaju was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2024 & has been associated with this company since 1 year 8 months . was documented.

  • Balance Sheet

    Jaju Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Charges

    A charge with Punjab National Bank amounted to Rs. 0.60 M with Charge ID 10216291 was registered on 29 Mar 2010. was recorded as a recent event.

  • Charges

    Progress on A charge with Punjab National Bank amounted to Rs. 0.50 M with Charge ID 10216302 was registered on 29 Mar 2010. was documented.

Frequently Asked Questions

  • What is the CIN of Jaju Pharmaceuticals Private Limited?

    The CIN of Jaju Pharmaceuticals Private Limited is U24231DL2002PTC117013.

  • Where is Jaju Pharmaceuticals Private Limited headquartered?

    Jaju Pharmaceuticals Private Limited is headquartered at Plot No. 6/51, Unit 23, Gf Tribhuvan Complex, Ishwar Nagar, Mathura, Road, New Delhi, Delhi, 110065.

  • When was Jaju Pharmaceuticals Private Limited incorporated?

    Jaju Pharmaceuticals Private Limited was incorporated on 17 September 2002.

  • Who are the current directors of Jaju Pharmaceuticals Private Limited?

    The current directors of Jaju Pharmaceuticals Private Limited are

  • What is the primary industry of Jaju Pharmaceuticals Private Limited?

    The primary industry of Jaju Pharmaceuticals Private Limited is Manufacturing.

  • Is Jaju Pharmaceuticals Private Limited a listed company?

    Jaju Pharmaceuticals Private Limited is unlisted.

  • What is the capital structure of Jaju Pharmaceuticals Private Limited?

    The authorized capital of Jaju Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.79 M.

  • What is the compliance status of Jaju Pharmaceuticals Private Limited?

    The compliance status of Jaju Pharmaceuticals Private Limited is Compliant.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial